sodium nitroprusside in 0.9% sodium chloride
NDC 70436-205, sodium nitroprusside in 0.9% sodium chloride, injection, from Slate Run Pharmaceuticals, LLC.
- Product NDC
- 70436-205
- Status
- Listed
- Labeler
- Slate Run Pharmaceuticals, LLC
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215846
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70436-205 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SODIUM NITROPRUSSIDE.2 mg/mL
Pharmacologic classes
Vasodilation [PE]; Vasodilator [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70436-205-80 | 70436020580 | 1 VIAL, SINGLE-DOSE in 1 CARTON (70436-205-80) / 50 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/6f02e4ac-5f7c-4003-b9b7-283f489cddb0
Use it
Look up 70436-205 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70436-205 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70436-205. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.